Erudio Healtherudio.com
Sponsor
Groupe Oncologie Radiotherapie Tete et Cou trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Groupe Oncologie Radiotherapie Tete et Cou yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Groupe Oncologie Radiotherapie Tete et Cou: GORTEC 2014-04, NIVOPOSTOP and TPExtreme. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Groupe Oncologie Radiotherapie Tete et Cou). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NIVOPOSTOP NCT03576417 · Groupe Oncologie Radiotherapie Tete et Cou DeepView → | high-risk resected head and neck squamous cell carcinoma | Phase 3 | Deep | View | |||
| GORTEC 2014-04 NCT03070366 · Groupe Oncologie Radiotherapie Tete et Cou FocusedView → | head and neck squamous cell carcinoma with oligometastases | Phase 2 | Focused | View | |||
| TPExtreme NCT02268695 · Groupe Oncologie Radiotherapie Tete et Cou FocusedView → | Not given | Phase 2 | Focused | View | |||